REJOICE-PanTumor01: A phase 2 signal-seeking study of raludotatug deruxtecan (R-DXd) in patients with advanced or metastatic gynecologic or genitourinary tumors.

Authors: Laurence Albiges, Kenichi Harano, Kathleen N. Moore, Thomas Powles, Toon Van Gorp, Laura Palmeri, Laura Winters, Soham Mahato, Jie Lin, Petar Jelinic, Susana N. Banerjee

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3158

Source: Full article

---

Abstract

TPS3158